Nithya Desikan

2017

In 2017, Nithya Desikan earned a total compensation of $1.2M as Chief Commercial Officer at RHYTHM PHARMACEUTICALS.

Compensation breakdown

Bonus$100,000
Non-Equity Incentive Plan$66,780
Option Awards$832,497
Salary$158,100
Total$1,157,377

Desikan received $832.5K in option awards, accounting for 72% of the total pay in 2017.

Desikan also received $100K in bonus, $66.8K in non-equity incentive plan and $158.1K in salary.

Rankings

In 2017, Nithya Desikan's compensation ranked 8,263rd out of 14,666 executives tracked by ExecPay. In other words, Desikan earned more than 43.7% of executives.

ClassificationRankingPercentile
All
8,263
out of 14,666
44th
Division
Manufacturing
3,123
out of 5,772
46th
Major group
Chemicals And Allied Products
1,032
out of 2,075
50th
Industry group
Drugs
812
out of 1,731
53rd
Industry
Pharmaceutical Preparations
635
out of 1,333
52nd
Source: SEC filing on April 30, 2018.

Desikan's colleagues

We found two more compensation records of executives who worked with Nithya Desikan at RHYTHM PHARMACEUTICALS in 2017.

2017

Keith Gottesdiener

RHYTHM PHARMACEUTICALS

Chief Executive Officer

2017

Hunter Smith

RHYTHM PHARMACEUTICALS

Chief Financial Officer

News

In-depth

You may also like